🇺🇸 FDA
Patent

US 9827353

Cross-linked fatty acid-based biomaterials

granted A61KA61K31/225A61K31/355

Quick answer

US patent 9827353 (Cross-linked fatty acid-based biomaterials) held by ATRIUM MEDICAL CORPORATION expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ATRIUM MEDICAL CORPORATION
Grant date
Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/225, A61K31/355, A61P, A61P41/00